Supporting Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced significantly improved financial results.

United statesVanderbilt universityPharma reditrexExchange commissionCumberland emerging technologies incLife sciences centerPrnewswire cumberland pharmaceuticals incClinical development programsCumberland pharmaceuticals incKyowa kirin incProduct divisionProducts grants programTreating infantsSupporting studySystemic sclerosisDuchenne muscular dystrophy